US Treasury proposes sweeping limits on investment in Chinese biotechnology
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
The Trump administration proposed adding biotechnology to sectors restricted under the Comprehensive Outbound Investment National Security Act. The rule would bar US companies from financial transactions with Chinese biotech and equipment firms while still allowing American drugmakers to license medicines invented in China.
Continue in the app — vote & join in ➔Source: STAT News · via ahirlevel.hu